Pacira Pharmaceuticals(DE:82P)
€32.800.00 (0.00%)
DE:82P
Pacira Pharmaceuticals earnings date
€32.80
At close:0.00 (0.00%)
Pacira Pharmaceuticals (82P) Q1 2023 Earnings Report
0 Followers
DE:82P Q1 2023 EPS Results
- Actual EPS
- EUR 0.48
- Consensus EPS
- EUR 0.56
- Beat/Miss
- Missed by -EUR 0.08
- One Year Ago EPS
- EUR 0.58
DE:82P Q1 2023 Revenue Results
- Actual Revenue
- EUR 145.84M
- Expected Revenue
- EUR 144.79M
- Beat/Miss
- Beat by +EUR 1.05M
- YoY Revenue Growth
- +1.49%
Earnings Announcement Details
- Quarter
- Q1 2023
- Date
- 05/03/2023
- Time
- Before Open
- Conference Call
- Wednesday, May 3, 2023
DE:82P Upcoming Earnings
Pacira Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q1 2023 Earnings Call Audio
DE:82P Q1 2023 Earnings Call
0:00 / 0:00
Q1 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:82P Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | ―- | 0.52 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.690.63 | 0.64 | -0.29% (-0.00) | |
| Aug 04, 2026 | 2026 (Q2) | 0.590.66 | 0.67 | -1.35% (-0.01) | |
| Apr 30, 2026 | 2026 (Q1) | 0.500.55 | 0.56 | -3.23% (-0.02) | |
| Feb 26, 2026 | 2025 (Q4) | 0.820.52 | 0.83 | -37.36% (-0.31) | |
| Nov 06, 2025 | 2025 (Q3) | 0.620.64 | 0.72 | -11.39% (-0.08) | |
| Aug 05, 2025 | 2025 (Q2) | 0.650.67 | 0.81 | -16.85% (-0.14) | |
| May 08, 2025 | 2025 (Q1) | 0.540.56 | 0.56 | 0.00% (+0.00) | |
| Feb 27, 2025 | 2024 (Q4) | 0.760.83 | 0.81 | 2.25% (+0.02) | |
| Nov 06, 2024 | 2024 (Q3) | 0.640.72 | 0.65 | 9.72% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

